Planning to attend BPI Europe in Vienna this April? Abzena’s cell line development experts will be on hand exhibiting in booth #917 and speaking at the event.  They would welcome the opportunity to learn more about your complex biologics and bioconjugates needs and to discuss how our enhanced cell line development platform, AbZelectPRO, can de-risk and accelerate your path to IND and beyond.

Presentation Title: AbZelectPRO™ – Powering the Fast Track from DNA to Clinic

Speaker: Tanya Knight, Sr. Manager, Cell Line Development

Presentation Summary:
Our fully integrated AbZelectPRO™ platform enables the rapid delivery of stable, high-producing cell lines to support the production of antibodies and more difficult-to-express proteins. The platform combines our AbZelectPRO™ CHO-K1 and AbZelectPRO™-KO GS knockout cell lines together with ProteoNic’s 2G UNic® vector technology and, supported by our comprehensive analytics capabilities, provides a state-of-the-art offering to support our clients as they transition from R&D into preclinical and clinical development.

Schedule a meeting with our cell line development experts at BPI